您的购物车当前为空
LCS3是一种可逆和非竞争性的谷胱甘肽二硫化物还原酶(GSR)和硫氧还蛋白还原酶1(TXNRD1)的协同抑制剂,IC50分别为3.3μM 和3.8μM。LCS3具有抗肿瘤活性,可诱导细胞凋亡,可用于研究肺腺癌(LUAD)。


为众多的药物研发团队赋能,
让新药发现更简单!
LCS3是一种可逆和非竞争性的谷胱甘肽二硫化物还原酶(GSR)和硫氧还蛋白还原酶1(TXNRD1)的协同抑制剂,IC50分别为3.3μM 和3.8μM。LCS3具有抗肿瘤活性,可诱导细胞凋亡,可用于研究肺腺癌(LUAD)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 497 | In stock | |
| 5 mg | ¥ 1,230 | In stock | |
| 10 mg | ¥ 1,960 | In stock | |
| 25 mg | ¥ 3,290 | In stock | |
| 50 mg | ¥ 4,830 | In stock | |
| 100 mg | ¥ 6,880 | In stock | |
| 500 mg | ¥ 13,800 | In stock |
LCS3 相关产品
| 产品描述 | LCS3 is a reversible and non-competitive synergistic inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50s of 3.3 μM and 3.8 μM, respectively. LCS3 has antitumour activity, induces apoptosis and can be used in the study of lung adenocarcinoma (LUAD). |
| 靶点活性 | GSR:3.3 µM, TXNRD1:3.8 µM, M. tuberculosis:0.098 µM(MIC) |
| 体外活性 | LCS3 (5 nM-10 µM;96小时)有效抑制肺癌细胞系,而非转化肺细胞未显示出抑制迹象。[1] LCS3 (3 µM;3、6及12小时)在敏感的肺腺癌(LUAD)细胞中诱导ROS和NRF2途径激活。[1] LCS3 (3 µM;96小时)通过诱导凋亡,选择性地杀死肺腺癌(LUAD)细胞系。[1] |
| 分子量 | 266.64 |
| 分子式 | C11H7ClN2O4 |
| CAS No. | 109844-92-0 |
| Smiles | [O-][N+](=O)C1=CC=C(O1)C(=O)NC1=CC=C(Cl)C=C1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 112.5 mg/mL (421.9 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (15 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容